Anesthesiology Doctors in Kellogg, ID Accepting Medicare

1 Anesthesiology doctors found. Showing 1 - 1

Mr. Loren Ken Zeitz, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25 Jacobs Gulch, Kellogg, ID 83837 Phone: 208-784-1221    Fax: 208-786-1019

News Archive

Reduced risk of heart disease for mothers who breastfeed

According to a new study, women who breastfeed their babies for a minimum of 6 months after giving birth have a reduced risk of heart disease in later life.

Artificial pancreas may improve glucose control in type 1 diabetics

A new study describes how patients could benefit from the use of newly available automatic closed-loop systems to administer insulin, popularly called "the artificial pancreas".

Stanford researchers use DNA minicircles to induce pluripotency in stem cells from human fat

Tiny circles of DNA are the key to a new and easier way to transform stem cells from human fat into induced pluripotent stem cells for use in regenerative medicine, say scientists at the Stanford University School of Medicine. Unlike other commonly used techniques, the method, which is based on standard molecular biology practices, does not use viruses to introduce genes into the cells or permanently alter a cell's genome.

AGA Medical Holdings announces settlement of patent infringement lawsuit with Medtronic

AGA Medical Holdings, Inc. today announced the settlement of a patent infringement lawsuit between the company and Medtronic, Inc. This dispute relates to the January 2007 patent infringement action against the company, filed by Medtronic, Inc., alleging that substantially all of AGA Medical's AMPLATZER® occluder and vascular plug devices infringe three of Medtronic's method and apparatus patents on shape memory alloy stents (U.S. Patent Nos. 5,190,546, 6,306,141 and 5,067,957, collectively known as "the Jervis patents").

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.

Read more Medical News

› Verified 7 days ago